There is consistent evidence from RCTs and real-world studies that SGLT2i use in type 1 diabetes is associated with an increased risk of DKA [14]
GLP-1(7-36) can suppress glucagon secretion in cells by increasing cAMP levels, activating PKA and EPAC, leading to a decrease in intracellular calcium concentration and reduced glucagon release
Subsequently, we showed that GLP-1 induces satiety equally well in people with obesity [10]
Together, we look at your childs growth pattern, eating habits, and home environment, and build a plan around the eight areas that actually move the needle: sleep, food, feeding, eating, movement, screens, self-love, and family culture
no head-to-head trials with approved agents have been conducted
If you have questions about weight management postpartum, reach out to your provider